Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study

标题
Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study
作者
关键词
-
出版物
CLINICAL CANCER RESEARCH
Volume 24, Issue 12, Pages 2771-2779
出版商
American Association for Cancer Research (AACR)
发表日期
2018-03-21
DOI
10.1158/1078-0432.ccr-17-2398

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started